GC Corp.
Research GC Corp. (005250.KS) on Bullrun: market cap KRW 432.25B, dividend yield 3.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker005250.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CurrencyKRW
- Market capKRW 432.25B
- Dividend yield3.1%
- Financial periodQ2 2026
- RevenueKRW 596.27B
- Net incomeKRW 1.55B
- Free cash flow-KRW 9.45B
- Gross margin28.8%
Valuation Snapshot
latest market cap is KRW 432.25B; dividend yield is 3.1%.
Peer valuation comparison
Latest dividend yield is 3.14% versus a Healthcare sector median of 2.4% (30.8% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 432.25B | n/a | 3.1% | 300 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 300 KRW, yield 3.1%.
About GC Corp.
GC Corp. operates as a biotechnology company. The company provides prescription drugs and over-the-counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is GC Corp.'s market cap?
GC Corp.'s market capitalization is KRW 432.25B.
Does GC Corp. pay a dividend?
GC Corp. has a dividend yield of 3.1%.
What does GC Corp. do?
GC Corp. operates as a biotechnology company. The company provides prescription drugs and over-the-counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services.